Fast and Simplified Method for High Through-put Isolation of miRNA from Highly Purified High Density Lipoprotein. 2016

Mulugeta Seneshaw, and Faridoddin Mirshahi, and Hae-Ki Min, and Amon Asgharpour, and Shervin Mirshahi, and Kalyani Daita, and Sherry Boyett, and Prasanna K Santhekadur, and Michael Fuchs, and Arun J Sanyal
Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University.

Small non-coding RNAs (miRNAs) have been implicated in a variety of human diseases including metabolic syndromes. They may be utilized as biomarkers for diagnosis and prognosis or may serve as targets for drug development, respectively. Recently it has been shown that miRNAs are carried in lipoproteins, particularly high density lipoproteins (HDL) and are delivered to recipient cells for uptake. This raises the possibility that miRNAs play a critical and pivotal role in cellular and organ function via regulation of gene expression as well as messenger for cell-cell communications and crosstalk between organs. Current methods for miRNA isolation from purified HDL are impractical when utilizing small samples on a large scale. This is largely due to the time consuming and laborious methods used for lipoprotein isolation. We have developed a simplified approach to rapidly isolate purified HDL suitable for miRNA analysis from plasma samples. This method should facilitate investigations into the role of miRNAs in health and disease and in particular provide new insights into the variety of biological functions, outside of the reverse cholesterol transport, that have been ascribed to HDL. Also, the miRNA species which are present in HDL can provide valuable information of clinical biomarkers for diagnosis of various diseases.

UI MeSH Term Description Entries
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D004587 Electrophoresis, Agar Gel Electrophoresis in which agar or agarose gel is used as the diffusion medium. Electrophoresis, Agarose Gel,Agar Gel Electrophoresis,Agarose Gel Electrophoresis,Gel Electrophoresis, Agar,Gel Electrophoresis, Agarose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D060888 Real-Time Polymerase Chain Reaction Methods used for detecting the amplified DNA products from the polymerase chain reaction as they accumulate instead of at the end of the reaction. Kinetic Polymerase Chain Reaction,Quantitative Real-Time PCR,Quantitative Real-Time Polymerase Chain Reaction,Real-Time PCR,PCR, Quantitative Real-Time,PCR, Real-Time,PCRs, Quantitative Real-Time,PCRs, Real-Time,Quantitative Real Time PCR,Quantitative Real Time Polymerase Chain Reaction,Quantitative Real-Time PCRs,Real Time PCR,Real Time Polymerase Chain Reaction,Real-Time PCR, Quantitative,Real-Time PCRs,Real-Time PCRs, Quantitative
D020133 Reverse Transcriptase Polymerase Chain Reaction A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols. Polymerase Chain Reaction, Reverse Transcriptase,Reverse Transcriptase PCR,PCR, Reverse Transcriptase,Transcriptase PCR, Reverse
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Mulugeta Seneshaw, and Faridoddin Mirshahi, and Hae-Ki Min, and Amon Asgharpour, and Shervin Mirshahi, and Kalyani Daita, and Sherry Boyett, and Prasanna K Santhekadur, and Michael Fuchs, and Arun J Sanyal
February 1987, Journal of neuroimmunology,
Mulugeta Seneshaw, and Faridoddin Mirshahi, and Hae-Ki Min, and Amon Asgharpour, and Shervin Mirshahi, and Kalyani Daita, and Sherry Boyett, and Prasanna K Santhekadur, and Michael Fuchs, and Arun J Sanyal
January 1970, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Mulugeta Seneshaw, and Faridoddin Mirshahi, and Hae-Ki Min, and Amon Asgharpour, and Shervin Mirshahi, and Kalyani Daita, and Sherry Boyett, and Prasanna K Santhekadur, and Michael Fuchs, and Arun J Sanyal
December 1985, Journal of clinical microbiology,
Mulugeta Seneshaw, and Faridoddin Mirshahi, and Hae-Ki Min, and Amon Asgharpour, and Shervin Mirshahi, and Kalyani Daita, and Sherry Boyett, and Prasanna K Santhekadur, and Michael Fuchs, and Arun J Sanyal
May 2012, BioTechniques,
Mulugeta Seneshaw, and Faridoddin Mirshahi, and Hae-Ki Min, and Amon Asgharpour, and Shervin Mirshahi, and Kalyani Daita, and Sherry Boyett, and Prasanna K Santhekadur, and Michael Fuchs, and Arun J Sanyal
November 2019, American journal of physiology. Renal physiology,
Mulugeta Seneshaw, and Faridoddin Mirshahi, and Hae-Ki Min, and Amon Asgharpour, and Shervin Mirshahi, and Kalyani Daita, and Sherry Boyett, and Prasanna K Santhekadur, and Michael Fuchs, and Arun J Sanyal
August 1977, Endocrinology,
Mulugeta Seneshaw, and Faridoddin Mirshahi, and Hae-Ki Min, and Amon Asgharpour, and Shervin Mirshahi, and Kalyani Daita, and Sherry Boyett, and Prasanna K Santhekadur, and Michael Fuchs, and Arun J Sanyal
January 2006, Molekuliarnaia biologiia,
Mulugeta Seneshaw, and Faridoddin Mirshahi, and Hae-Ki Min, and Amon Asgharpour, and Shervin Mirshahi, and Kalyani Daita, and Sherry Boyett, and Prasanna K Santhekadur, and Michael Fuchs, and Arun J Sanyal
October 1985, Biochimica et biophysica acta,
Mulugeta Seneshaw, and Faridoddin Mirshahi, and Hae-Ki Min, and Amon Asgharpour, and Shervin Mirshahi, and Kalyani Daita, and Sherry Boyett, and Prasanna K Santhekadur, and Michael Fuchs, and Arun J Sanyal
January 2008, Progress in cardiovascular nursing,
Mulugeta Seneshaw, and Faridoddin Mirshahi, and Hae-Ki Min, and Amon Asgharpour, and Shervin Mirshahi, and Kalyani Daita, and Sherry Boyett, and Prasanna K Santhekadur, and Michael Fuchs, and Arun J Sanyal
December 1972, The Biochemical journal,
Copied contents to your clipboard!